Eugene Medlock
Inventor
Stats
- 6 US patents issued
- 20 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 6 US Patents Issued
- 20 US Applications Filed
- 239 Total Citation Count
- Jun 26, 2013 Most Recent Filing
- Mar 16, 2001 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| MEDAREX, INC. | 1
| 2010
|
| E. R. SQUIBB & SONS, L.L.C. | 2
2 2 | 2003
2010 2012 |
| MEDAREX, L.L.C. | 1
1 | 2012
2013 |
| AMGEN INC. | 4
1 4 1 2 3 1 | 2001
2004 2005 2006 2009 2010 2013 |
Inventor Addresses
| Address | Duration |
|---|---|
| West Lake Village, CA, US | Nov 12, 09 - Jun 30, 11 |
| Westlake Village, CA | Mar 28, 02 - May 31, 07 |
| Westlake Village, CA, US | Oct 20, 05 - Feb 06, 14 |
| Westlake, CA | Feb 05, 04 - Feb 05, 04 |
| Westlake, CA, US | May 18, 10 - Jul 04, 13 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 10 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
| C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 8 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2014/0037,635 | 2014 | METHODS OF TREATMENT USING IL-17E ANTAGONISTS | 2 |
| 2013/0171,168 | 2013 | Human Anti-OPGL Neutralizing Antibodies as Selective OPGL Pathway Inhibitors | 0 |
| 2013/0164,292 | 2013 | Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors | 0 |
| 8455629 | 2013 | Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors | 0 |
| 8367063 | 2013 | Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.